Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.70 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.70 |
| ▸ | NPC1 | O15118 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | NCF1 | P14598 | 6/20 | 0.47 |
| ▸ | HRAS | P01112 | 1/20 | 0.46 |
| ▸ | KRAS | P01116 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.45 |
| ▸ | PPARD | Q03181 | 2/20 | 0.45 |
| ▸ | PPARA | Q07869 | 2/20 | 0.45 |
| ▸ | CPT2 | P23786 | 1/20 | 0.45 |
| ▸ | CPT1A | P50416 | 1/20 | 0.45 |
| ▸ | CPT1B | Q92523 | 1/20 | 0.45 |
| ▸ | AGXT | P21549 | 2/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20110894 | 0.91 | KDM4E (0.66) | KDM4EMAPK1TDP1NPC1MAPT | |
| SCHEMBL18775628 | 0.91 | KDM4E (0.58) | KDM4EMAPK1TDP1NPC1MAPT | |
| SCHEMBL15726984 | 0.86 | KDM4E (0.56) | KDM4EMAPK1TDP1NPC1MAPT | |
| SCHEMBL4067116 | 0.85 | KDM4E (0.70) | KDM4EMAPK1TDP1NPC1MAPT | |
| SCHEMBL8674825 | 0.83 | TDP1 (1.00) | KDM4EMAPK1TDP1NPC1MAPT | |
| SCHEMBL15657734 | 0.83 | TDP1 (1.00) | KDM4EMAPK1TDP1NPC1MAPT | |
| SCHEMBL8673201 | 0.83 | TDP1 (1.00) | KDM4EMAPK1TDP1NPC1MAPT | |
| SCHEMBL14356067 | 0.80 | KDM4E (0.61) | KDM4EMAPK1TDP1NPC1MAPT | |
| SCHEMBL9339737 | 0.79 | KDM4E (0.60) | KDM4EMAPK1TDP1NPC1MAPT | |
| SCHEMBL16021964 | 0.79 | KDM4E (0.82) | KDM4EMAPK1TDP1NPC1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118671-A1 | BETA-NAPHTHOL ETHER SULFONATES, PROCESSES FOR PREPARING THEM AND USE THEREOF AS BRIGHTNESS IMPROVERS | BASF SE (DE) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118671-A1 | BETA-NAPHTHOL ETHER SULFONATES, PROCESSES FOR PREPARING THEM AND USE THEREOF AS BRIGHTNESS IMPROVERS | LBR, IK, NES | KDM4E 4380/4885MAPK1 1775/4885TDP1 3855/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.